deoxycytidine has been researched along with epiglucan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ma, L; Sun, Y; Wang, X; Xiong, M; Zhang, X; Zhao, Y | 1 |
| Chae, JS; Choi, YS; Kang, H; Lee, S; Shin, H; Song, Y; Yeom, CH | 1 |
2 other study(ies) available for deoxycytidine and epiglucan
| Article | Year |
|---|---|
Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan.
Topics: Antineoplastic Agents; beta-Glucans; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Gemcitabine; HeLa Cells; Humans; Lung Neoplasms; Molecular Structure; Structure-Activity Relationship | 2018 |
Yeast (1 → 3)-(1 → 6)-β-d-glucan alleviates immunosuppression in gemcitabine-treated mice.
Topics: Animals; beta-Glucans; Bone Marrow Cells; Cell Line, Tumor; Cytokines; Deoxycytidine; Gemcitabine; Hematopoiesis; Immunosuppression Therapy; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Pancytopenia; Spleen; Yeasts | 2019 |